These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 7280000)
1. In vitro detection of possible in vivo drug interactions. Part 2: A study of the effect of hydrochlorothiazide and frusemide on the partition coefficient and solubility characteristics of propranolol hydrochloride. Al-Janabi II; Anber SA; Fikrat HT Pharmazie; 1981; 36(7):485-8. PubMed ID: 7280000 [TBL] [Abstract][Full Text] [Related]
2. In vitro detection of possible in vivo drug interactions. Part 1. The effect of hydrochlorothiazide and frusemide on the in vitro absorption characteristics of propranolol hydrochloride. Anber SA; Al-Janabi II; Mustafa RM; Razzo FN Pharmazie; 1981 Jun; 36(6):425-7. PubMed ID: 7279990 [TBL] [Abstract][Full Text] [Related]
3. Determination of hydrochlorothiazide, triamterene and propranolol hydrochloride by the spectrophotometric method and high-performance liquid chromatography (HPLC). Jończyk A; Nowakowska Z Acta Pol Pharm; 2001; 58(5):339-44. PubMed ID: 11876440 [TBL] [Abstract][Full Text] [Related]
4. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Javadzadeh Y; Musaalrezaei L; Nokhodchi A Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery. Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416 [TBL] [Abstract][Full Text] [Related]
6. X-ray powder diffraction data for selected drugs: furosemide, hydrochlorothiazide, naproxen, naproxen sodium, propranolol hydrochloride, and the halopheniramine maleates. De Camp WH J Assoc Off Anal Chem; 1984; 67(5):927-33. PubMed ID: 6501157 [TBL] [Abstract][Full Text] [Related]
7. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Garg A; Gupta M; Bhargava HN Eur J Pharm Biopharm; 2007 Nov; 67(3):725-31. PubMed ID: 17543513 [TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride. Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667 [TBL] [Abstract][Full Text] [Related]
9. Effect of hydrophilic natural gums in formulation of oral-controlled release matrix tablets of propranolol hydrochloride. Rajesh KS; Venkataraju MP; Gowda DV Pak J Pharm Sci; 2009 Apr; 22(2):211-9. PubMed ID: 19339235 [TBL] [Abstract][Full Text] [Related]
10. Matrix based controlled release tablets of propranolol hydrochloride. Ganga S; Singh J Pharmazie; 1991 Nov; 46(11):816-7. PubMed ID: 1811237 [No Abstract] [Full Text] [Related]
11. Stability studies of expired tablets of metoprolol tartrate and propranolol hydrochloride. Part 2. Dissolution study. Jasińska M; Karwowski B; Orszulak-Michalak D; Kurczewska U Acta Pol Pharm; 2009; 66(6):703-7. PubMed ID: 20050535 [TBL] [Abstract][Full Text] [Related]
12. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. Patel VM; Prajapati BG; Patel MM AAPS PharmSciTech; 2007 Jun; 8(2):Article 45. PubMed ID: 17622120 [TBL] [Abstract][Full Text] [Related]
13. Discrepancy among dissolution rates of commercial tablets as a function of dissolution method. Part 5: In vitro/in vivo correlation for chlorpromazine hydrochloride tablets. Ammar HO; Khalil RM; Omar SM Pharmazie; 1993 Dec; 48(12):932-5. PubMed ID: 8115438 [TBL] [Abstract][Full Text] [Related]
14. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation. Dukić-Ott A; Remon JP; Foreman P; Vervaet C Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625 [TBL] [Abstract][Full Text] [Related]
15. Hydrodynamically balanced systems as sustained release dosage forms for propranolol hydrochloride. Khattar D; Ahuja A; Khar RK Pharmazie; 1990 May; 45(5):356-8. PubMed ID: 2395898 [TBL] [Abstract][Full Text] [Related]
16. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4. Polonini H; da Silva SL; Brandão MAF; Bauters T; De Moerloose B; Ferreira AO Int J Pharm Compd; 2018; 22(6):516-526. PubMed ID: 30384353 [TBL] [Abstract][Full Text] [Related]
17. Effects of oxygen plasma treatment on the surface wettability and dissolution of furosemide compacts. Naseem A; Olliff CJ; Martini LG; Lloyd AW J Pharm Pharmacol; 2003 Nov; 55(11):1473-8. PubMed ID: 14713357 [TBL] [Abstract][Full Text] [Related]
18. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Souliman S; Blanquet S; Beyssac E; Cardot JM Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713 [TBL] [Abstract][Full Text] [Related]